Tradestie Institutional Equity Comparison Engine
ARIA vs INCY โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
INCY Overall Edge
INCY Captures Institutional Edge (4โ0 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Incyte Genomics Inc (INCY) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ARIA trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus INCY at 13.9x Forward P/E and 32.2% operating margin (+14.0% YoY). In options structure, ARIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against INCY sits in CONSOLIDATION (73rd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
INCY
ARIA N/M vs INCY 13.9x Fwd P/E
Growth & Margin Winner
INCY
Op Margin N/A vs 32.2% ยท YoY N/A vs +14.0%
Momentum & Technical Winner
INCY
1Y -17.0% vs +14.1% ยท 52W Pos 0% vs 72%
Options & Structure Winner
INCY
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (73rd %ile IV)
ARIA
US Equity
ARIA
Institutional Equity
$21.03
-3.52% 1D
Market Cap
N/A
1M Return
-11.55%
1Y Return
-16.97%
Forward P/E
N/M
Unified AI Score
47.7 / 100
HOLD
Tech 50.0
Fund 52.0
Flow 50.0
Mom 60.0
INCY
NASDAQ
Incyte Genomics Inc
Services-Commercial Physical & Biological Research
$120.27
-0.58% 1D
Market Cap
$24.7B
1M Return
+6.37%
1Y Return
+14.1%
Forward P/E
13.9x
Unified AI Score
58.9 / 100
HOLD
Tech 45.0
Fund 56.0
Flow 68.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ARIA -16.97%
INCY +14.1%
Spread: +15.92 pp (INCY Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
ARIA TTM Op. Margin: N/A
INCY TTM Op. Margin: 32.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ARIA vs INCY. Trailing 12-month operating profitability (ARIA N/A vs INCY 32.2%) and valuation multiples (ARIA N/M vs INCY 13.9x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ARIA | INCY | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $24.7B | Larger Scale | INCY |
| Trailing P/E Ratio Valuation | N/M | 61.7x | Lower Multiple | INCY |
| Forward P/E Ratio Valuation | N/M | 13.9x | Lower Multiple | INCY |
| Revenue Growth (YoY) Growth | N/A | +14.0% | Higher Growth | INCY |
| Operating Margin (TTM) Profitability | N/A | 32.2% | Higher Margin | INCY |
| Net Profit Margin Profitability | N/A | 6.7% | Higher Margin | INCY |
| Return on Equity (ROE) Capital Efficiency | N/A | 7.8% | Higher ROE | INCY |
| 52-Week Range Position Momentum | 0% ($21โ$27) | 72% ($89โ$133) | Stronger Trend | INCY |
| Beta / 30D Volatility Risk Regime | 1.92ฮฒ ยท 43% Vol | 0.30ฮฒ ยท 35% Vol | Lower Realized Risk | INCY |
| Unified Institutional Score Composite Signal | 47.7 / 100 (HOLD) | 58.9 / 100 (HOLD) | Higher Composite | INCY |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ARIA vs INCY Buy Guide
ARIA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
INCY
CONSOLIDATION
78d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
73rd %ile
IV Regime
Elevated (60thโ80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ARIA nor INCY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.